Oligometastatic non-small cell lung cancer: Where do we go next?

Lung Cancer. 2017 Apr:106:145-147. doi: 10.1016/j.lungcan.2016.12.014. Epub 2016 Dec 26.

Authors

Nauman Malik¹, David Palma²

Affiliations

¹ Division of Radiation Oncology, University of Western Ontario, London Health Sciences Centre, London, Canada, 790 Commissioners Rd E, London ON, N6A4L6.
² Division of Radiation Oncology, University of Western Ontario, London Health Sciences Centre, London, Canada, 790 Commissioners Rd E, London ON, N6A4L6. Electronic address: [email protected].

PMID: 28062090
DOI: 10.1016/j.lungcan.2016.12.014

No abstract available

Publication types

Editorial

MeSH terms

Carcinoma, Non-Small-Cell Lung / diagnosis*
Carcinoma, Non-Small-Cell Lung / mortality
Carcinoma, Non-Small-Cell Lung / therapy*
Combined Modality Therapy / adverse effects
Combined Modality Therapy / methods
Disease Management
Humans
Lung Neoplasms / diagnosis*
Lung Neoplasms / mortality
Lung Neoplasms / pathology
Lung Neoplasms / therapy*
Neoplasm Metastasis
Neoplasm Staging
Randomized Controlled Trials as Topic
Treatment Outcome